| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.2 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.2 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.3 |